checkAd

     110  0 Kommentare Misonix to Participate in Upcoming March Investor Conferences

    FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Cowen 41st Annual Healthcare Conference and the Oppenheimer 31st Annual Healthcare Conference on March 4th and March 16th, respectively. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be available to host one-on-one meetings with investors who are registered to attend the conferences.

    • Cowen 41st Annual Healthcare Conference
      Date: Thursday, March 4, 2021
      Presentation: 9:50 a.m. ET
    • Oppenheimer 31st Annual Healthcare Conference
      Date: Tuesday, March 16, 2021
      Presentation: 4:30 p.m. ET

    For more information about the conferences or to schedule a virtual one-on-one meeting with management, please contact your conference representative. Alternatively, please contact Misonix’s investor relations firm, JCIR, at mson@jcir.com.

    Lesen Sie auch

    About Misonix, Inc.
    Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company's web site at www.misonix.com.

    Contact:  
    Joe Dwyer Norberto Aja, Jennifer Neuman
    Chief Financial Officer JCIR
    Misonix, Inc. 212-835-8500 or mson@jcir.com
    631-927-9113  



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Misonix to Participate in Upcoming March Investor Conferences FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) - Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be …